Leptin/Melanocortin Pathway in Cholelithiasis Patients: A Diagnostic Perspective

Area of Science:

• Endocrinology
• Gastroenterology
• Molecular Biology

Background:

• Cholelithiasis (gallstone disease) is a prevalent inflammatory gallbladder condition.
• Obesity and weight gain are significant risk factors for gallstones.
• Leptin and melanocortin pathways regulate appetite and energy homeostasis, potentially influencing gallstone risk.

Purpose of the Study:

• To investigate the relationship between specific protein levels and cholelithiasis.
• To determine if proteins in the leptin and melanocortin pathways are associated with gallstone disease.

Main Methods:

• Analyzed protein levels (LEP, LEPR, TrkB, BDNF, POMC, MC4R) in 44 cholelithiasis patients and 44 controls.
• Utilized Enzyme-Linked Immunosorbent Assay (ELISA) for protein quantification.
• Statistical analysis performed using SPSS and GraphPad Prism software.

Main Results:

• Significantly lower levels of MC4R, TrkB, BDNF, and POMC proteins were observed in patients with cholelithiasis compared to controls (p < 0.05).
• No significant difference in leptin (LEP) and leptin receptor (LEPR) levels was found between the groups.

Conclusions:

• MC4R, TrkB, BDNF, and POMC proteins, part of the leptin and melanocortin pathways, may play a role in cholelithiasis pathogenesis.
• Further research is warranted to elucidate the precise mechanisms.
• Findings provide a basis for future investigations into gallstone disease.